1
|
Kajos LF, Molics B, Than P, Gőbel G, Elmer D, Pónusz-Kovács D, Csákvári T, Kovács B, Horváth L, Bódis J, Boncz I. Comparative analysis of the quality of life regarding patients who underwent hip replacement in public versus private hospitals in Hungary. Sci Rep 2024; 14:10031. [PMID: 38693216 PMCID: PMC11063203 DOI: 10.1038/s41598-024-60720-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2023] [Accepted: 04/26/2024] [Indexed: 05/03/2024] Open
Abstract
The study aimed to investigate the impact of hip replacement surgery on the quality of life and to compare the outcomes by sociodemographic and surgical data in Hungarian public and private hospitals. Patients were selected at the Department of Orthopaedics (Clinical Centre, University of Pécs) and at the Da Vinci Private Clinic in Pécs. Patients completed the SF-36 and Oxford Hip Score (OHS) questionnaires before the surgery, 6 weeks and 3 months later. We also evaluated socio-demographic data, disease and surgical conditions. The research involved 128 patients, 60 patients in public, 68 patients in private hospital. Despite the different sociodemographic characteristics and surgical outcomes of public and private healthcare patients, both groups had significantly improved the quality of life 3 months after hip replacement surgery measured by OHS and SF-36 physical health scores (p < 0.001). In the mental health score, only the patients of the private health sector showed a significant improvement (p < 0.001). The extent of improvement did not differ between the two healthcare sectors according to the OHS questionnaire (p = 0.985). While the SF-36 physical health score showed a higher improvement for public patients (p = 0.027), the mental health score showed a higher improvement for private patients (p = 0.015).
Collapse
Affiliation(s)
- Luca Fanni Kajos
- Institute for Health Insurance, Faculty of Health Sciences, University of Pécs, Pécs, 7621, Hungary.
- Doctoral School of Health Sciences, Faculty of Health Sciences, University of Pécs, Pécs, 7621, Hungary.
- National Laboratory on Human Reproduction, Pécs, 7624, Hungary.
| | - Bálint Molics
- Institute of Physiotherapy and Sport Science, Faculty of Health Sciences, University of Pécs, Pécs, 7621, Hungary
| | - Péter Than
- Department of Orthopaedics, Clinical Centre, Medical School, University of Pécs, Pécs, 7632, Hungary
| | - Gyula Gőbel
- Da Vinci Private Clinic, Pécs, 7635, Hungary
| | - Diána Elmer
- Institute for Health Insurance, Faculty of Health Sciences, University of Pécs, Pécs, 7621, Hungary
- National Laboratory on Human Reproduction, Pécs, 7624, Hungary
| | - Dalma Pónusz-Kovács
- Institute for Health Insurance, Faculty of Health Sciences, University of Pécs, Pécs, 7621, Hungary
- Doctoral School of Health Sciences, Faculty of Health Sciences, University of Pécs, Pécs, 7621, Hungary
- National Laboratory on Human Reproduction, Pécs, 7624, Hungary
| | - Tímea Csákvári
- Institute for Health Insurance, Faculty of Health Sciences, University of Pécs, Pécs, 7621, Hungary
| | - Bettina Kovács
- Institute for Health Insurance, Faculty of Health Sciences, University of Pécs, Pécs, 7621, Hungary
| | - Lilla Horváth
- Institute for Health Insurance, Faculty of Health Sciences, University of Pécs, Pécs, 7621, Hungary
| | - József Bódis
- Institute for Health Insurance, Faculty of Health Sciences, University of Pécs, Pécs, 7621, Hungary
- National Laboratory on Human Reproduction, Pécs, 7624, Hungary
- Department of Obstetrics and Gynaecology, Clinical Centre, Medical School, University of Pécs, Pécs, 7624, Hungary
| | - Imre Boncz
- Institute for Health Insurance, Faculty of Health Sciences, University of Pécs, Pécs, 7621, Hungary
- National Laboratory on Human Reproduction, Pécs, 7624, Hungary
| |
Collapse
|
2
|
Czétány P, Balló A, Márk L, Török A, Szántó Á, Máté G. An Alternative Application of Magnetic-Activated Cell Sorting: CD45 and CD235a Based Purification of Semen and Testicular Tissue Samples. Int J Mol Sci 2024; 25:3627. [PMID: 38612438 PMCID: PMC11011735 DOI: 10.3390/ijms25073627] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2024] [Revised: 03/18/2024] [Accepted: 03/23/2024] [Indexed: 04/14/2024] Open
Abstract
Magnetic activated cell sorting (MACS) is a well-known sperm selection technique, which is able to remove apoptotic spermatozoa from semen samples using the classic annexinV based method. Leukocytes and erythrocytes in semen samples or in testicular tissue processed for in vitro fertilization (IVF) could exert detrimental effects on sperm. In the current study, we rethought the aforementioned technique and used magnetic microbeads conjugated with anti-CD45/CD235a antibodies to eliminate contaminating leukocytes and erythrocytes from leukocytospermic semen samples and testicular tissue samples gained via testicular sperm extraction (TESE). With this technique, a 15.7- and a 30.8-fold reduction could be achieved in the ratio of leukocytes in semen and in the number of erythrocytes in TESE samples, respectively. Our results show that MACS is a method worth to reconsider, with more potential alternative applications. Investigations to find molecules labeling high-quality sperm population and the development of positive selection procedures based on these might be a direction of future research.
Collapse
Affiliation(s)
- Péter Czétány
- Urology Clinic, University of Pécs Clinical Centre, 7621 Pécs, Hungary; (P.C.); (A.B.); (G.M.)
- National Laboratory on Human Reproduction, University of Pécs, 7624 Pécs, Hungary;
| | - András Balló
- Urology Clinic, University of Pécs Clinical Centre, 7621 Pécs, Hungary; (P.C.); (A.B.); (G.M.)
- National Laboratory on Human Reproduction, University of Pécs, 7624 Pécs, Hungary;
- Pannon Reproduction Institute, 8300 Tapolca, Hungary;
| | - László Márk
- National Laboratory on Human Reproduction, University of Pécs, 7624 Pécs, Hungary;
- Department of Analytical Biochemistry, Institute of Biochemistry and Medical Chemistry, University of Pécs Medical School, 7624 Pécs, Hungary
- MTA-PTE Human Reproduction Scientific Research Group, 7624 Pécs, Hungary
| | - Attila Török
- Pannon Reproduction Institute, 8300 Tapolca, Hungary;
| | - Árpád Szántó
- Urology Clinic, University of Pécs Clinical Centre, 7621 Pécs, Hungary; (P.C.); (A.B.); (G.M.)
- National Laboratory on Human Reproduction, University of Pécs, 7624 Pécs, Hungary;
| | - Gábor Máté
- Urology Clinic, University of Pécs Clinical Centre, 7621 Pécs, Hungary; (P.C.); (A.B.); (G.M.)
- National Laboratory on Human Reproduction, University of Pécs, 7624 Pécs, Hungary;
- Pannon Reproduction Institute, 8300 Tapolca, Hungary;
| |
Collapse
|
3
|
Kőszegi T, Horváth-Szalai Z, Ragán D, Kósa B, Szirmay B, Kurdi C, Kovács GL, Mühl D. Measurement of Urinary Gc-Globulin by a Fluorescence ELISA Technique: Method Validation and Clinical Evaluation in Septic Patients-A Pilot Study. Molecules 2023; 28:6864. [PMID: 37836706 PMCID: PMC10574505 DOI: 10.3390/molecules28196864] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2023] [Revised: 09/22/2023] [Accepted: 09/27/2023] [Indexed: 10/15/2023] Open
Abstract
A major complication of sepsis is the development of acute kidney injury (AKI). In case of acute tubular damage, Gc-globulin, a known serum sepsis marker is increasingly filtrated into the urine therefore, urinary Gc-globulin (u-Gc) levels may predict septic AKI. We developed and validated a competitive fluorescence ELISA method for u-Gc measurement. Serum and urine samples from septic patients were collected in three consecutive days (T1, T2, T3) and data were compared to controls. Intra- and interassay imprecisions were CV < 14% and CV < 20%, respectively, with a recovery close to 100%. Controls and septic patients differed (p < 0.001) in their u-Gc/u-creatinine levels at admission (T1, median: 0.51 vs. 79.1 µg/mmol), T2 (median: 0.51 vs. 57.8 µg/mmol) and T3 (median: 0.51 vs. 55.6 µg/mmol). Septic patients with AKI expressed higher u-Gc/u-creatinine values than those without AKI at T1 (median: 23.6 vs. 136.5 µg/mmol, p < 0.01) and T3 (median: 34.4 vs. 75.8 µg/mmol, p < 0.05). AKI-2 stage patients exhibited more increased u-Gc/u-creatinine levels at T1 (median: 207.1 vs. 53.3 µg/mmol, p < 0.05) than AKI-1 stage individuals. Moderate correlations (p < 0.001) were observed between u-Gc/u-creatinine and se-urea, se-creatinine, se-hsCRP, WBC, u-total protein, u-albumin, u-orosomucoid/u-creatinine, and u-Cystatin C/u-creatinine levels. U-Gc testing may have a predictive value for AKI in septic patients.
Collapse
Affiliation(s)
- Tamás Kőszegi
- Department of Laboratory Medicine, Medical School, University of Pécs, 7624 Pécs, Hungary
- János Szentágothai Research Center, University of Pécs, 7624 Pécs, Hungary
- Hungarian National Laboratory on Reproduction, University of Pécs, 7624 Pécs, Hungary
| | - Zoltán Horváth-Szalai
- Department of Laboratory Medicine, Medical School, University of Pécs, 7624 Pécs, Hungary
- János Szentágothai Research Center, University of Pécs, 7624 Pécs, Hungary
| | - Dániel Ragán
- Department of Laboratory Medicine, Medical School, University of Pécs, 7624 Pécs, Hungary
| | - Brigitta Kósa
- Department of Laboratory Medicine, Medical School, University of Pécs, 7624 Pécs, Hungary
- János Szentágothai Research Center, University of Pécs, 7624 Pécs, Hungary
| | - Balázs Szirmay
- Department of Laboratory Medicine, Medical School, University of Pécs, 7624 Pécs, Hungary
| | - Csilla Kurdi
- János Szentágothai Research Center, University of Pécs, 7624 Pécs, Hungary
- Hungarian National Laboratory on Reproduction, University of Pécs, 7624 Pécs, Hungary
| | - Gábor L. Kovács
- Department of Laboratory Medicine, Medical School, University of Pécs, 7624 Pécs, Hungary
- János Szentágothai Research Center, University of Pécs, 7624 Pécs, Hungary
- Hungarian National Laboratory on Reproduction, University of Pécs, 7624 Pécs, Hungary
| | - Diána Mühl
- Department of Anesthesiology and Intensive Therapy, Medical School, University of Pécs, 7624 Pécs, Hungary
| |
Collapse
|
4
|
Ahmadi H, Aghebati-Maleki L, Rashidiani S, Csabai T, Nnaemeka OB, Szekeres-Bartho J. Long-Term Effects of ART on the Health of the Offspring. Int J Mol Sci 2023; 24:13564. [PMID: 37686370 PMCID: PMC10487905 DOI: 10.3390/ijms241713564] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2023] [Revised: 08/29/2023] [Accepted: 08/29/2023] [Indexed: 09/10/2023] Open
Abstract
Assisted reproductive technologies (ART) significantly increase the chance of successful pregnancy and live birth in infertile couples. The different procedures for ART, including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), and gamete intrafallopian tube transfer (GIFT), are widely used to overcome infertility-related problems. In spite of its inarguable usefulness, concerns about the health consequences of ART-conceived babies have been raised. There are reports about the association of ART with birth defects and health complications, e.g., malignancies, high blood pressure, generalized vascular functional disorders, asthma and metabolic disorders in later life. It has been suggested that hormonal treatment of the mother, and the artificial environment during the manipulation of gametes and embryos may cause genomic and epigenetic alterations and subsequent complications in the health status of ART-conceived babies. In the current study, we aimed to review the possible long-term consequences of different ART procedures on the subsequent health status of ART-conceived offspring, considering the confounding factors that might account for/contribute to the long-term consequences.
Collapse
Affiliation(s)
- Hamid Ahmadi
- Department of Medical Biology and Central Electron Microscope Laboratory, Medical School, Pécs University, 7624 Pécs, Hungary; (H.A.); (T.C.)
| | - Leili Aghebati-Maleki
- Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz 5165665931, Iran;
- Immunology Research Center, Tabriz University of Medical Sciences, Tabriz 5165665931, Iran
| | - Shima Rashidiani
- Department of Medical Biochemistry, Medical School, Pécs University, 7624 Pécs, Hungary;
| | - Timea Csabai
- Department of Medical Biology and Central Electron Microscope Laboratory, Medical School, Pécs University, 7624 Pécs, Hungary; (H.A.); (T.C.)
- János Szentágothai Research Centre, Pécs University, 7624 Pécs, Hungary
- Endocrine Studies, Centre of Excellence, Pécs University, 7624 Pécs, Hungary
- National Laboratory of Human Reproduction, 7624 Pécs, Hungary
| | - Obodo Basil Nnaemeka
- Department of Laboratory Diagnostics, Faculty of Health Sciences, Pécs University, 7621 Pécs, Hungary;
| | - Julia Szekeres-Bartho
- Department of Medical Biology and Central Electron Microscope Laboratory, Medical School, Pécs University, 7624 Pécs, Hungary; (H.A.); (T.C.)
- János Szentágothai Research Centre, Pécs University, 7624 Pécs, Hungary
- Endocrine Studies, Centre of Excellence, Pécs University, 7624 Pécs, Hungary
- National Laboratory of Human Reproduction, 7624 Pécs, Hungary
- MTA—PTE Human Reproduction Research Group, 7624 Pecs, Hungary
| |
Collapse
|
5
|
Kurdi C, Lelovics V, Hesszenberger D, Lajtai A, Lakatos Á, Herczeg R, Gödöny K, Mauchart P, Várnagy Á, Kovács GL, Kőszegi T. Amino Acid Profiling of Follicular Fluid in Assisted Reproduction Reveals Important Roles of Several Amino Acids in Patients with Insulin Resistance. Int J Mol Sci 2023; 24:12458. [PMID: 37569834 PMCID: PMC10419978 DOI: 10.3390/ijms241512458] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2023] [Revised: 08/02/2023] [Accepted: 08/03/2023] [Indexed: 08/13/2023] Open
Abstract
The global prevalence of insulin resistance (IR) is increasing continuously, influencing metabolic parameters and fertility. The metabolic changes due to IR can alter the molecular composition of plasma and other body fluids. Follicular fluid (FF) is derived mainly from plasma, and it is a critical microenvironment for the developing oocytes. It contains various metabolites and amino acids, and the quality of the oocytes is linked at least partially to amino acid metabolism. Our goal was to quantitatively determine the amino acid (AA) profile of FF in IVF patients and to compare IR and non-insulin resistance (NIR) groups to investigate the AA changes in their FF. Using UHPLC-based methods, we quantified the main 20 amino acids from human FF samples in the IR and NIR groups. Several amino acids (aspartate, glycine, glutamate, and cysteine) differed significantly (p < 0.05 or less) between the two groups. The most significant alterations between the IR and NIR groups were related to the glutathione metabolic pathway involving glycine, serine, and threonine. Since insulin resistance alters the amino acid composition of the FF, the oocytes may undergo metabolism-induced changes resulting in poor oocyte quality and less fertility in the insulin resistance groups.
Collapse
Affiliation(s)
- Csilla Kurdi
- János Szentágothai Research Center, University of Pécs, Ifjúság u. 20, 7624 Pécs, Hungary; (C.K.); (G.L.K.)
- Department of Laboratory Medicine, Medical School, University of Pécs, Ifjúság u. 13, 7624 Pécs, Hungary (A.L.)
- National Laboratory on Human Reproduction, University of Pécs, 7624 Pécs, Hungary
| | - Vanessza Lelovics
- Department of Laboratory Medicine, Medical School, University of Pécs, Ifjúság u. 13, 7624 Pécs, Hungary (A.L.)
| | - Dávid Hesszenberger
- Department of Laboratory Medicine, Medical School, University of Pécs, Ifjúság u. 13, 7624 Pécs, Hungary (A.L.)
| | - Anikó Lajtai
- Department of Laboratory Medicine, Medical School, University of Pécs, Ifjúság u. 13, 7624 Pécs, Hungary (A.L.)
| | - Ágnes Lakatos
- Department of Laboratory Medicine, Medical School, University of Pécs, Ifjúság u. 13, 7624 Pécs, Hungary (A.L.)
| | - Róbert Herczeg
- János Szentágothai Research Center, University of Pécs, Ifjúság u. 20, 7624 Pécs, Hungary; (C.K.); (G.L.K.)
| | - Krisztina Gödöny
- National Laboratory on Human Reproduction, University of Pécs, 7624 Pécs, Hungary
- Department of Obstetrics and Gynecology, Medical School, University of Pécs, Édesanyák útja 17, 7624 Pécs, Hungary
- MTA-PTE Human Reproduction Scientific Research Group, University of Pécs, 7624 Pécs, Hungary
| | - Péter Mauchart
- National Laboratory on Human Reproduction, University of Pécs, 7624 Pécs, Hungary
- Department of Obstetrics and Gynecology, Medical School, University of Pécs, Édesanyák útja 17, 7624 Pécs, Hungary
- MTA-PTE Human Reproduction Scientific Research Group, University of Pécs, 7624 Pécs, Hungary
| | - Ákos Várnagy
- National Laboratory on Human Reproduction, University of Pécs, 7624 Pécs, Hungary
- Department of Obstetrics and Gynecology, Medical School, University of Pécs, Édesanyák útja 17, 7624 Pécs, Hungary
- MTA-PTE Human Reproduction Scientific Research Group, University of Pécs, 7624 Pécs, Hungary
| | - Gábor L. Kovács
- János Szentágothai Research Center, University of Pécs, Ifjúság u. 20, 7624 Pécs, Hungary; (C.K.); (G.L.K.)
- Department of Laboratory Medicine, Medical School, University of Pécs, Ifjúság u. 13, 7624 Pécs, Hungary (A.L.)
- National Laboratory on Human Reproduction, University of Pécs, 7624 Pécs, Hungary
| | - Tamás Kőszegi
- János Szentágothai Research Center, University of Pécs, Ifjúság u. 20, 7624 Pécs, Hungary; (C.K.); (G.L.K.)
- Department of Laboratory Medicine, Medical School, University of Pécs, Ifjúság u. 13, 7624 Pécs, Hungary (A.L.)
- National Laboratory on Human Reproduction, University of Pécs, 7624 Pécs, Hungary
| |
Collapse
|
6
|
Balló A, Czétány P, Busznyákné KS, Márk L, Mike N, Török A, Szántó Á, Máté G. Oxido-Reduction Potential as a Method to Determine Oxidative Stress in Semen Samples. Int J Mol Sci 2023; 24:11981. [PMID: 37569357 PMCID: PMC10418886 DOI: 10.3390/ijms241511981] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2023] [Revised: 07/16/2023] [Accepted: 07/24/2023] [Indexed: 08/13/2023] Open
Abstract
There are different estimates for the incidence of infertility. Its occurrence may vary from area to area, but on average, it affects 15% of couples and 10-12% of men worldwide. Many aspects of infertility can be linked to reactive oxygen species (ROS) and the process of oxidative stress (OS). The association between poor semen quality and OS is well known. Unfortunately, there is no accepted protocol for the diagnosis and treatment of OS in andrology. Oxido-reduction potential (ORP) measurement is a new method for determining the ratio between oxidant and antioxidant molecules. Currently, ORP measurement is one of the fastest and most user-friendly methods of andrological OS determination and our goals were to confirm published correlations between ORP values and sperm parameters, examine how sperm concentration influences these results, and investigate whether intracellular ROS formations are also manifested in the ORP values or not after artificial ROS induction. Intracellular ROS formations were induced by menadione (superoxide anion inducer), hydrogen peroxide, and tert-butyl hydroperoxide (lipid peroxidation inducer) treatments; sperm parameters like motility and viability were determined with an SCA Scope system, and ORP changes were recorded by the Mioxsys system. Significant correlations were noticed among the ORP, spermatozoa concentration, motility, progressive motility, and viability. Nevertheless, only the ORP value after normalization with the sperm count correlated with these parameters. Due to normalization, very low and very high sperm concentrations can give misleading results. The means of the non-normalized ORP values were almost the same. All of the applied treatments resulted in decreases in the viability, motility, and progressive motility, and interestingly, altered ORP levels were detected. In addition, it was determined that seminal plasma had a significant protective effect on spermatozoa. The elimination of seminal plasma caused higher sensitivity of spermatozoa against used OS inducers, and higher ORP levels and decreased viabilities and motilities were measured. The ORP level could be a good indicator of male OS; however, in cases of low and high sperm counts, its result can be misleading. Overall, the conclusion can be drawn that ORP determination is a suitable method for detecting intracellular ROS accumulation, but it has limitations that still need to be clarified.
Collapse
Affiliation(s)
- András Balló
- Pannon Reproduction Institute, 8300 Tapolca, Hungary; (A.B.); (K.S.B.); (A.T.)
- Urology Clinic, University of Pécs Clinical Centre, 7621 Pécs, Hungary; (P.C.); (Á.S.)
- National Laboratory on Human Reproduction, University of Pécs, 7624 Pécs, Hungary;
| | - Péter Czétány
- Urology Clinic, University of Pécs Clinical Centre, 7621 Pécs, Hungary; (P.C.); (Á.S.)
- National Laboratory on Human Reproduction, University of Pécs, 7624 Pécs, Hungary;
| | | | - László Márk
- National Laboratory on Human Reproduction, University of Pécs, 7624 Pécs, Hungary;
- Department of Analytical Biochemistry, Institute of Biochemistry and Medical Chemistry, University of Pécs Medical School, 7624 Pécs, Hungary
- MTA-PTE Human Reproduction Scientific Research Group, 7624 Pécs, Hungary
| | - Nóra Mike
- Szentágothai Research Centre, Department of Physiology, Medical School, University of Pécs, 7624 Pécs, Hungary;
| | - Attila Török
- Pannon Reproduction Institute, 8300 Tapolca, Hungary; (A.B.); (K.S.B.); (A.T.)
- National Laboratory on Human Reproduction, University of Pécs, 7624 Pécs, Hungary;
| | - Árpád Szántó
- Urology Clinic, University of Pécs Clinical Centre, 7621 Pécs, Hungary; (P.C.); (Á.S.)
- National Laboratory on Human Reproduction, University of Pécs, 7624 Pécs, Hungary;
| | - Gábor Máté
- Pannon Reproduction Institute, 8300 Tapolca, Hungary; (A.B.); (K.S.B.); (A.T.)
- Urology Clinic, University of Pécs Clinical Centre, 7621 Pécs, Hungary; (P.C.); (Á.S.)
- National Laboratory on Human Reproduction, University of Pécs, 7624 Pécs, Hungary;
| |
Collapse
|
7
|
Pandur E, Pap R, Jánosa G, Horváth A, Sipos K. The Role of Fractalkine in the Regulation of Endometrial Iron Metabolism in Iron Deficiency. Int J Mol Sci 2023; 24:9917. [PMID: 37373063 DOI: 10.3390/ijms24129917] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2023] [Revised: 06/06/2023] [Accepted: 06/07/2023] [Indexed: 06/29/2023] Open
Abstract
Iron is a crucial element in the human body. Endometrial iron metabolism is implicated in endometrium receptivity and embryo implantation. Disturbances of the maternal as well as the endometrial iron homeostasis, such as iron deficiency, can contribute to the reduced development of the fetus and could cause an increased risk of adverse pregnancy outcomes. Fractalkine is a unique chemokine that plays a role in the communication between the mother and the fetus. It has been demonstrated that FKN is involved in the development of endometrial receptivity and embryo implantation, and it functions as a regulator of iron metabolism. In the present study, we examined the effect of FKN on the iron metabolism of HEC-1A endometrial cells in a state of iron deficiency mediated by desferrioxamine treatment. Based on the findings, FKN enhances the expression of iron metabolism-related genes in iron deficiency and modifies the iron uptake via transferrin receptor 1 and divalent metal transporter-1, and iron release via ferroportin. FKN can activate the release of iron from heme-containing proteins by elevating the level of heme oxygenase-1, contributing to the redistribution of intracellular iron content. It was revealed that the endometrium cells express both mitoferrin-1 and 2 and that their levels are not dependent on the iron availability of the cells. FKN may also contribute to maintaining mitochondrial iron homeostasis. FKN can improve the deteriorating effect of iron deficiency in HEC-1A endometrium cells, which may contribute to the development of receptivity and/or provide iron delivery towards the embryo.
Collapse
Affiliation(s)
- Edina Pandur
- Department of Pharmaceutical Biology, Faculty of Pharmacy, University of Pécs, H-7624 Pécs, Hungary
- National Laboratory on Human Reproduction, University of Pécs, H-7624 Pécs, Hungary
| | - Ramóna Pap
- Department of Pharmaceutical Biology, Faculty of Pharmacy, University of Pécs, H-7624 Pécs, Hungary
- National Laboratory on Human Reproduction, University of Pécs, H-7624 Pécs, Hungary
| | - Gergely Jánosa
- Department of Pharmaceutical Biology, Faculty of Pharmacy, University of Pécs, H-7624 Pécs, Hungary
| | - Adrienn Horváth
- Department of Pharmaceutical Biology, Faculty of Pharmacy, University of Pécs, H-7624 Pécs, Hungary
| | - Katalin Sipos
- Department of Pharmaceutical Biology, Faculty of Pharmacy, University of Pécs, H-7624 Pécs, Hungary
- National Laboratory on Human Reproduction, University of Pécs, H-7624 Pécs, Hungary
| |
Collapse
|
8
|
Csákvári T, Pónusz-Kovács D, Kajos LF, Elmer D, Pónusz R, Kovács B, Várnagy Á, Kovács K, Bódis J, Boncz I. Prevalence and Annual Health Insurance Cost of Endometriosis in Hungary-A Nationwide Study Based on Routinely Collected, Real-World Health Insurance Claims Data. Healthcare (Basel) 2023; 11:healthcare11101448. [PMID: 37239734 DOI: 10.3390/healthcare11101448] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2023] [Revised: 04/28/2023] [Accepted: 05/15/2023] [Indexed: 05/28/2023] Open
Abstract
Endometriosis is a disease that is often diagnosed late and that may lead to significant reduction in quality of life and serious complications (e.g., infertility). We aimed to assess the prevalence and the annual, nationwide health insurance treatment cost of endometriosis in Hungary using a quantitative, descriptive, cross-sectional method, focusing on the year 2019. We used claims data obtained from the Hungarian National Health Insurance Fund Administration (NHIFA). Patient numbers, total and age-specific prevalence, annual health insurance expenditure, and the distribution of costs across age groups were determined. The NHIFA spent a total of HUF 619.95 million (EUR 1.91 million) on endometriosis treatment. The highest number of patients and prevalence (10,058 women, 197.3 per 100,000) were found in outpatient care. In acute inpatient care, prevalence was substantially lower (23.5 per 100,000). Endometriosis, regardless of its type, affects 30-39-year-olds in the highest number: 4397 women (694.96 per 100,000) in this age group were affected in 2019. The average annual health insurance expenditure per capita was EUR 189.45. In addition to early detection and diagnosis of endometriosis, it is of pivotal importance to provide adequate therapy to reduce costs and reduce the burden on the care system.
Collapse
Affiliation(s)
- Tímea Csákvári
- Institute of Health Insurance, Faculty of Health Sciences, University of Pécs, 7621 Pécs, Hungary
- National Laboratory on Human Reproduction, University of Pécs, 7622 Pécs, Hungary
| | - Dalma Pónusz-Kovács
- Institute of Health Insurance, Faculty of Health Sciences, University of Pécs, 7621 Pécs, Hungary
- National Laboratory on Human Reproduction, University of Pécs, 7622 Pécs, Hungary
| | - Luca Fanni Kajos
- Institute of Health Insurance, Faculty of Health Sciences, University of Pécs, 7621 Pécs, Hungary
- National Laboratory on Human Reproduction, University of Pécs, 7622 Pécs, Hungary
| | - Diána Elmer
- Institute of Health Insurance, Faculty of Health Sciences, University of Pécs, 7621 Pécs, Hungary
- National Laboratory on Human Reproduction, University of Pécs, 7622 Pécs, Hungary
| | - Róbert Pónusz
- Institute of Health Insurance, Faculty of Health Sciences, University of Pécs, 7621 Pécs, Hungary
- National Laboratory on Human Reproduction, University of Pécs, 7622 Pécs, Hungary
| | - Bettina Kovács
- National Laboratory on Human Reproduction, University of Pécs, 7622 Pécs, Hungary
| | - Ákos Várnagy
- National Laboratory on Human Reproduction, University of Pécs, 7622 Pécs, Hungary
- Department of Obstetrics and Gynecology, Clinical Center, Medical School, University of Pécs, 7622 Pécs, Hungary
| | - Kálmán Kovács
- National Laboratory on Human Reproduction, University of Pécs, 7622 Pécs, Hungary
- Department of Obstetrics and Gynecology, Clinical Center, Medical School, University of Pécs, 7622 Pécs, Hungary
| | - József Bódis
- Institute of Health Insurance, Faculty of Health Sciences, University of Pécs, 7621 Pécs, Hungary
- National Laboratory on Human Reproduction, University of Pécs, 7622 Pécs, Hungary
- Department of Obstetrics and Gynecology, Clinical Center, Medical School, University of Pécs, 7622 Pécs, Hungary
| | - Imre Boncz
- Institute of Health Insurance, Faculty of Health Sciences, University of Pécs, 7621 Pécs, Hungary
- National Laboratory on Human Reproduction, University of Pécs, 7622 Pécs, Hungary
| |
Collapse
|
9
|
Bencze B, Temesfői V, Das S, Papp H, Kaltenecker P, Kuczmog A, Jakab F, Kocsis B, Kőszegi T. Development of a novel, entirely herbal-based mouthwash effective against common oral bacteria and SARS-CoV-2. BMC Complement Med Ther 2023; 23:138. [PMID: 37127611 PMCID: PMC10150350 DOI: 10.1186/s12906-023-03956-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2022] [Accepted: 04/11/2023] [Indexed: 05/03/2023] Open
Abstract
BACKGROUND Parallel to the growth of the oral healthcare market, there is a constantly increasing demand for natural products as well. Many customers prefer products that contain fewer toxic agents, therefore providing an environmentally friendly solution with the benefit of smaller risk to the user. Medieval and early modern medicinal knowledge might be useful when looking for natural, herbal-based components to develop modern products. Along with these considerations we created, tested, and compared an entirely natural mouthwash, named Herba Dei. METHODS The manufacturing procedure was standardized, and the created tincture was evaluated by GC/MS analysis for active compounds, experimentally tested in cell-based cytotoxicity, salivary protein integrity, cell-free antioxidant activity, anti-bacterial and anti-viral assays, and compared with three market-leading mouthwashes. RESULTS Our tincture did not show significant damage in the cytotoxicity assays to keratinocyte and Vero E6 cells and did not disrupt the low molecular weight salivary proteins. Its radical scavenging capacity surpassed that of two tested, partly natural, and synthetic mouthwashes, while its antibacterial activity was comparable to the tested products, or higher in the bacterial aerobic respiratory assay. The active compounds responsible for the effects include naturally occurring phenylpropanoids, terpenes, and terpenoids. Our mouthwash proved to be effective in vitro in lowering the copy number of SARS-CoV-2 in circumstances mimicking the salivary environment. CONCLUSIONS The developed product might be a useful tool to impede the transmission and spread of SARS-CoV-2 in interpersonal contact and aerosol-generating conditions. Our mouthwash can help reduce the oral bacterial flora and has an antioxidant activity that facilitates wound healing and prevents adverse effects of smoke in the oral cavity.
Collapse
Affiliation(s)
- Bálint Bencze
- Department of Laboratory Medicine, Clinical Centre, Medical School, University of Pécs, Ifjúság Út 13, Pécs, 7624, Hungary
| | - Viktória Temesfői
- Department of Laboratory Medicine, Clinical Centre, Medical School, University of Pécs, Ifjúság Út 13, Pécs, 7624, Hungary.
- Lab-On-a-Chip Research Group, János Szentágothai Research Centre, University of Pécs, Ifjúság Útja 20, Pécs, 7624, Hungary.
- Hungarian National Laboratory On Reproduction, University of Pécs, Pécs, 7624, Hungary.
| | - Sourav Das
- Department of Laboratory Medicine, Clinical Centre, Medical School, University of Pécs, Ifjúság Út 13, Pécs, 7624, Hungary
- Lab-On-a-Chip Research Group, János Szentágothai Research Centre, University of Pécs, Ifjúság Útja 20, Pécs, 7624, Hungary
| | - Henrietta Papp
- National Laboratory of Virology, University of Pécs, Ifjúság Útja 20, Pécs, 7624, Hungary
- Institute of Biology, Faculty of Sciences, University of Pécs, Ifjúság Útja 6, Pécs, 7624, Hungary
| | - Péter Kaltenecker
- Lab-On-a-Chip Research Group, János Szentágothai Research Centre, University of Pécs, Ifjúság Útja 20, Pécs, 7624, Hungary
- Hungarian National Laboratory On Reproduction, University of Pécs, Pécs, 7624, Hungary
| | - Anett Kuczmog
- National Laboratory of Virology, University of Pécs, Ifjúság Útja 20, Pécs, 7624, Hungary
- Institute of Biology, Faculty of Sciences, University of Pécs, Ifjúság Útja 6, Pécs, 7624, Hungary
| | - Ferenc Jakab
- National Laboratory of Virology, University of Pécs, Ifjúság Útja 20, Pécs, 7624, Hungary
- Institute of Biology, Faculty of Sciences, University of Pécs, Ifjúság Útja 6, Pécs, 7624, Hungary
| | - Béla Kocsis
- Department of Medical Microbiology and Immunology, Clinical Centre, Medical School, University of Pécs, Szigeti Út 12, Pécs, 7624, Hungary
| | - Tamás Kőszegi
- Department of Laboratory Medicine, Clinical Centre, Medical School, University of Pécs, Ifjúság Út 13, Pécs, 7624, Hungary
- Lab-On-a-Chip Research Group, János Szentágothai Research Centre, University of Pécs, Ifjúság Útja 20, Pécs, 7624, Hungary
- Hungarian National Laboratory On Reproduction, University of Pécs, Pécs, 7624, Hungary
| |
Collapse
|
10
|
Csákvári T, Elmer D, Németh N, Komáromy M, Kajos LF, Kovács B, Boncz I. Assessing the per Capita Food Supply Trends of 38 OECD Countries between 2000 and 2019-A Joinpoint Regression Analysis. Life (Basel) 2023; 13:life13051091. [PMID: 37240736 DOI: 10.3390/life13051091] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2023] [Revised: 04/25/2023] [Accepted: 04/26/2023] [Indexed: 05/28/2023] Open
Abstract
Food supply has an impact on the prevalence of diet-related non-communicable diseases. We aimed to analyze the protein, fat (g/capita/day) and calorie (kcal/capita/day) supply from 2000 to 2019 as derived from the OECD Health Statistics database. A joinpoint regression was used to examine the number and location of breakpoints in the time series. The annual percent change (APC) was calculated using Joinpoint 4.9.0.0. The per capita daily kcal per nutrient was calculated for each country and the resulting percentage distributions were compared to the acceptable macronutrient distribution ranges. Protein, fat and calorie supplies have increased significantly between 2000 and 2019. Each started to show a much steeper, positive change between 2012 and 2014 (APCfat: 1.0; 95%CI: 0.8-1.1; APCprotein: 0.5; 95%CI: 0.3-0.6; APCkcal: 0.4; 95%CI: 0.3-0.5). In terms of the composition of the daily calorie intake per capita, the overall share of fat (+4.9%) and protein (+1.0%) increased between 2000 and 2019. We found significant differences among countries and also an increasing and optimal proportion of consumed protein per total calorie in all countries over the last two decades. We concluded that several countries have access to fat availability above the optimal level, which deserves particular attention from health policy makers in the fight against obesity and diet-related diseases.
Collapse
Affiliation(s)
- Tímea Csákvári
- Institute of Health Insurance, Faculty of Health Sciences, University of Pécs, 7621 Pécs, Hungary
- National Laboratory on Human Reproduction, University of Pécs, 7624 Pécs, Hungary
| | - Diána Elmer
- Institute of Health Insurance, Faculty of Health Sciences, University of Pécs, 7621 Pécs, Hungary
- National Laboratory on Human Reproduction, University of Pécs, 7624 Pécs, Hungary
| | - Noémi Németh
- Institute of Health Insurance, Faculty of Health Sciences, University of Pécs, 7621 Pécs, Hungary
| | - Márk Komáromy
- Institute of Health Insurance, Faculty of Health Sciences, University of Pécs, 7621 Pécs, Hungary
| | - Luca Fanni Kajos
- Institute of Health Insurance, Faculty of Health Sciences, University of Pécs, 7621 Pécs, Hungary
- National Laboratory on Human Reproduction, University of Pécs, 7624 Pécs, Hungary
| | - Bettina Kovács
- Institute of Health Insurance, Faculty of Health Sciences, University of Pécs, 7621 Pécs, Hungary
- National Laboratory on Human Reproduction, University of Pécs, 7624 Pécs, Hungary
| | - Imre Boncz
- Institute of Health Insurance, Faculty of Health Sciences, University of Pécs, 7621 Pécs, Hungary
- National Laboratory on Human Reproduction, University of Pécs, 7624 Pécs, Hungary
| |
Collapse
|